Lifeline Biotechnologies (LLBO) Stock Statistics & Valuation Metrics

Lifeline Biotechnologies has a market cap or net worth of $1.30M. The enterprise value is $10.37T.

Market Cap

$1.30M

Enterprise Value

$10.37T

Lifeline Biotechnologies has 4,348,921,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

4,348,921,000

Owned by Insiders

―

Owned by Institutions

<0.01%

Lifeline Biotechnologies’s return on equity (ROE) is -0.79 and return on invested capital (ROIC) is -11.35%.

Return on Equity (ROE)

-0.79

Return on Assets (ROA)

-0.10

Return on Invested Capital (ROIC)

-11.35%

Return on Capital Employed (ROCE)

-0.79

Revenue Per Employee

―

Profits Per Employee

―

Employee Count

0

Asset Turnover

0.00

Inventory Turnover

0.00

In the last 12 months, Lifeline Biotechnologies had revenue of 0 and earned -43.39K in profits. Earnings per share was 0.00.

Revenue

0

Gross Profit

0

Operating Income

-43.39K

Pretax Income

-43.39K

Net Income

-43.39K

EBITDA

-43.39K

Earnings Per Share (EPS)

0.00

Beta

484.38

52-Week Price Change

―

50-Day Moving Average

―

200-Day Moving Average

―

Relative Strength Index (RSI)

―

Average Volume (3m)

―

Lifeline Biotechnologies as a current ratio of 0.46, with Debt / Equity ratio of 592.56%

Current Ratio

0.46

Quick Ratio

0.46

Debt to Market Cap

0.03

Net Debt to EBITDA

-7.53

Interest Coverage Ratio

0.00

In the past 12 months, Lifeline Biotechnologies has paid 0 in taxes.

Income Tax

0

Effective Tax Rate

0.00

The average price target for Lifeline Biotechnologies is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

0

Revenue Growth Forecast

―

EPS Growth Forecast

―